Preliminary clinical trials and clinical pharmacologic studies with 5-(3,3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196) given orally.
D000284:Administration, Oral; D001806:Blood Urea Nitrogen; D002247:Carbon Isotopes; D004304:Dosage Forms; D005243:Feces / Q000032:analysis; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use* / Q000652:urine; D008111:Liver Function Tests; D009369:Neoplasms / Q000188:drug therapy*; D013997:Time Factors
D002247:Carbon Isotopes; D004304:Dosage Forms; D007093:Imidazoles